{"database": "lobbying", "table": "lobbying_activities", "rows": [[1915474, "a68fa7df-990e-49b9-83a3-1f2f7c82a7db", "Q4", "MEHLMAN CONSULTING, INC.", 284950, "THE CAMPAIGN FOR SUSTAINABLE RX PRICING", 2016, "fourth_quarter", "PHA", "Issues related to transparency and competition in the prescription drug market.\nS.3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES).\nS. 3335,  Fair Accountability and Innovative Research Drug Pricing Act of 2016 (FAIR).\nFood and Drug Administration Appropriations Act.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2017-01-17T13:54:23-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1915474"], "units": {}, "query_ms": 0.3476539859548211, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}